SCHEMBL24143540

SCHEMBL24143540

NCCc1cn(Cc2ccc(F)cc2F)c2cc(-c3ccncc3)ccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1D1 P20393 6/20 0.42
▸ DPP4 P27487 1/20 0.38
▸ DPP8 Q6V1X1 1/20 0.38
▸ NFATC1 O95644 1/20 0.37
▸ GSK3B P49841 1/20 0.37
▸ DYRK1A Q13627 1/20 0.37
▸ PTK2 Q05397 1/20 0.36
▸ SERPINE1 P05121 1/20 0.35
▸ PTGDR2 Q9Y5Y4 1/20 0.35
▸ HTR2A P28223 1/20 0.34
▸ CAPN1 P07384 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ HTR6 P50406 1/20 0.34
▸ MAPK13 O15264 1/20 0.34
▸ MAPK12 P53778 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24143557 0.88 CYP19A1 (0.45) NR1D1KDM4EMEN1MAPTHTT
SCHEMBL24143548 0.88 NFATC1 (0.50) NR1D1NFATC1GSK3BDYRK1ASERPINE1
SCHEMBL24144502 0.85 CYP19A1 (0.47) NR1D1GSK3BKDM4EMEN1HTT
SCHEMBL24143945 0.83 NR1D1 (0.48) NR1D1NFATC1GSK3BDYRK1APTK2
SCHEMBL24143944 0.81 NR1D1 (0.69) NR1D1
SCHEMBL24144070 0.81 HTR6 (0.54) NR1D1DYRK1ASERPINE1HTR6
SCHEMBL24142953 0.80 CYP19A1 (0.47) NR1D1SERPINE1HTR2AHTR6CHEK1
SCHEMBL24143743 0.80 NR1D1 (0.50) NR1D1HTR2AHTR6CHEK1
SCHEMBL24144465 0.78 NR1D1 (0.48) NR1D1HTR2AHTR6CHEK1
SCHEMBL24143664 0.77 NR1D1 (0.44) NR1D1HTR2ACAPN1CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021263278-A1 REV-ERB AGONISTS FOR THE TREATMENT OF TH17-MEDIATED INFLAMMATORY DISORDERS THE SCRIPPS RESEARCH INSTITUTE (US) 2021-12-30 — — WO disclosed
Send feedback